ACCESS Newswire
04 Feb 2023, 00:13 GMT+10
NEW YORK, NY / ACCESSWIRE / February 3, 2023 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.
AFRM Shareholders Click Here: https://www.zlk.com/pslra-1/affirm-class-action-submission-form?prid=36235&wire=1
TWST Shareholders Click Here: https://www.zlk.com/pslra-1/twist-bioscience-loss-submission-form?prid=36235&wire=1
GOTU Shareholders Click Here: https://www.zlk.com/pslra-1/gaotu-lawsuit-loss-submission-form?prid=36235&wire=1
* ADDITIONAL INFORMATION BELOW *
AFRM Lawsuit on behalf of: investors who purchased February 12, 2021 - December 15, 2021
Lead Plaintiff Deadline: February 6, 2023
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/affirm-class-action-submission-form?prid=36235&wire=1
According to the filed complaint, during the class period, Affirm Holdings, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Affirm's 'buy-now, pay-later' service facilitated excessive consumer debt, regulatory arbitrage, and data harvesting; (ii) the foregoing subjected Affirm to a heightened risk of regulatory scrutiny and enforcement action; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
This lawsuit is on behalf of a class of all persons and entities who purchased or otherwise acquired Twist common stock between December 13, 2019 and November 14, 2022, inclusive.
Lead Plaintiff Deadline: February 10, 2023
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/twist-bioscience-loss-submission-form?prid=36235&wire=1
According to the filed complaint, 1) as alleged in the November 15, 2022 report by Scorpion Capital, defendants overstated the commercial viability of Twist's synthetic DNA manufacturing technology; and 2) at the same time, defendants were engaging in accounting fraud and using unsustainable pricing to inflate the Company's true financial condition and prospects.
Gaotu Techedu Inc. F/K/A Gsx Techedu Inc. (NYSE:GOTU)
This lawsuit is on behalf of persons or entities who purchased or otherwise acquired publicly traded Gaotu American depository shares between March 5, 2021 and July 23, 2021, inclusive.
Lead Plaintiff Deadline : February 28, 2023
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/gaotu-lawsuit-loss-submission-form?prid=36235&wire=1
According to the filed complaint, (1) China was barring tutoring for profit in core school subjects, and this policy change would restrict foreign investment in a sector that had become essential to success in Chinese school exams; and (2) the impact such regulations would have on Gaotu's operations and profitability and the value of Company securities.
You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
SOURCE: Levi & Korsinsky, LLP
Get a daily dose of Cleveland Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Cleveland Star.
More InformationKABUL, Afghanistan: Afghanistan, long associated with war and instability, is quietly trying to rebrand itself as a destination for...
SANTA CLARA, California: Executives at Nvidia have quietly been cashing in on the AI frenzy. According to a report by the Financial...
NEW YORK, New York - Global stock indices closed with divergent performances on Tuesday, as investors weighed corporate earnings, central...
TORONTO, Canada: Canadian Prime Minister Mark Carney announced late on June 29 that trade negotiations with the U.S. have recommenced...
Vancouver, Canada: A high-stakes legal showdown is brewing in the world of athleisure. Lululemon, the Canadian brand known for its...
LONDON, U.K.: British oil giant Shell has denied reports that it is in talks to acquire rival oil company BP. The Wall Street Journal...
ABU DHABI, 19th June, 2025 (WAM) -- Cleveland Clinic Abu Dhabi has become the first and only research hospital in the UAE to receive...
ABU DHABI, 17th June, 2025 (WAM) -- Cleveland Clinic Abu Dhabi, part of the M42 group, has successfully introduced continuous infusion...
ABU DHABI, 9th June, 2025 (WAM) -- Cleveland Clinic Abu Dhabi has successfully performed the UAE's first robotic cytoreductive surgery...
ABU DHABI,16th May, 2025 (WAM) - Oracle Health, Cleveland Clinic, and G42 today announced a strategic partnership to develop a groundbreaking...
ABU DHABI, 6th May, 2025 (WAM) -- PureHealth and its subsidiary SEHA have partnered with the number one US children's hospital, Cincinnati...
Argentinian composer Lalo Schifrin, the genre-blending film and television composer behind the Mission: Impossible, Bullitt, and Cool...